The Patent Finder

Terms ending in 2039

Tesaro, Inc.

Every in-force patent on Tesaro, Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 11,730,725Niraparib Formulations
In force
 · High confidence
Tesaro, Inc.In forceHigh confidence
US 11,926,665Methods of Treating Cancer with ANTI-TIM-3 Antibodies
In force
 · Medium confidence
Tesaro, Inc.In forceMedium confidence
US 11,661,453Combination Therapies for Treating Cancer with Niraparib and PD-1 Inhibitors
In force
 · High confidence
Tesaro, Inc.In forceHigh confidence
US 11,801,240Combination Therapies and Uses Thereof
In force
 · High confidence
Tesaro, Inc.In forceHigh confidence
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited